Short answer
KLOW peptide is the market name for a four-component research blend in one 80 mg lyophilized vial: GHK-Cu 50 mg, BPC-157 10 mg, TB-500 10 mg and KPV 10 mg. It is GLOW (GHK-Cu + BPC-157 + TB-500) with KPV added. It is sold as a laboratory reference material; no studies of the blend itself have been published, only of each peptide separately, mostly in preclinical models.
Key facts
- Format: one lyophilized vial, 80 mg in total.
- Components: four, GHK-Cu 50 mg, BPC-157 10 mg, TB-500 10 mg, KPV 10 mg.
- Relation to GLOW: KLOW = GLOW + KPV 10 mg. GLOW is the 70 mg, three-component version.
- Relation to Wolverine: BPC-157 + TB-500 is the shared core of all three blends.
- Analysis: done per component and per lot; the KPV analysis is scheduled.
- Use: laboratory research only; not a medicine, food, cosmetic or supplement.
What Is KLOW Peptide?
"KLOW peptide" is how researchers and suppliers refer to a blend of four peptides supplied together in one vial. You will also see it written as "KLOW 80", "KLOW-80", "KLOW blend" or "KLOW stack". It is not a single molecule and not a compound with its own sequence: it is a co-formulated mix of four separate, well-known research peptides.
The name sits alongside "GLOW", a three-component blend that KLOW builds on. In the research-peptide market the two are used as a pair, and the practical difference between them is a single component, KPV. This guide sets out what each vial contains, how KLOW compares with GLOW and Wolverine, what the published research does and does not say, and how to read the analysis of a blend. It is a research reference, not usage advice.
KLOW 80 mg Composition
The Pepspan KLOW Blend is a lyophilized vial with a total content of 80 mg. GHK-Cu makes up most of the mass; the other three components are present in equal amounts of 10 mg. Other ratios are sold elsewhere (55 mg versions, for example), so when comparing "KLOW" listings, look at the per-component milligrams rather than the name.
| Component | Per vial | % of vial | What it is | Research area (preclinical) |
|---|---|---|---|---|
| GHK-Cu | 50 mg | 62.5% | Copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine | Extracellular matrix remodelling, gene expression |
| BPC-157 | 10 mg | 12.5% | Synthetic 15-amino-acid peptide from a gastric protein sequence | Tissue repair and angiogenesis models |
| TB-500 | 10 mg | 12.5% | Synthetic full-length thymosin beta-4 (43 amino acids) | Actin binding, cell migration |
| KPV | 10 mg | 12.5% | Tripeptide Lys-Pro-Val, C-terminal fragment of alpha-MSH | Inflammation models (NF-κB pathway) |
| Total | 80 mg | 100% |
The Four Components
BPC-157
BPC-157 ("Body Protection Compound") is a synthetic pentadecapeptide, 15 amino acids long, derived from a sequence of a gastric protein. Its formula is C62H98N16O22 and its molecular weight 1,419.53 g/mol. It has been studied in preclinical models (animals and in vitro) of tissue repair and angiogenesis; see Sikiric et al. (source 2).
TB-500
In Pepspan's blends TB-500 is the complete synthetic thymosin beta-4 molecule (43 amino acids), formula C212H350N56O78S, 4,963.44 g/mol. In the wider market the TB-500 name is sometimes applied to a shorter fragment, so the sequence should be confirmed on the listing. Thymosin beta-4 has been studied for its binding to G-actin and its role in cell migration; see Goldstein et al. (source 3).
GHK-Cu
GHK-Cu is the tripeptide glycyl-L-histidyl-L-lysine bound to copper(II): C14H24N6O4Cu, 403.92 g/mol. The copper gives the powder and its solutions a bluish tint. Published work, much of it by Pickart, has looked at extracellular matrix remodelling and gene expression (source 1).
KPV
KPV is the tripeptide Lys-Pro-Val, the C-terminal fragment of alpha-melanocyte-stimulating hormone (alpha-MSH): C16H30N4O4, 342.43 g/mol. It has been examined in inflammation models, involving the NF-κB pathway, without the melanogenic activity of the full hormone (sources 4 and 5). KPV is the only component that separates KLOW from GLOW.
Pepspan lists the components individually as well: BPC-157, TB-500 and GHK-Cu. For background, see the BPC-157 vs TB-500 comparison and the GHK-Cu guide.
KLOW vs GLOW vs Wolverine
KLOW is GLOW with KPV added; Wolverine is the BPC-157 + TB-500 core. The three differ only by which components are included, and the shared components are present in the same amounts: GHK-Cu 50 mg where included, and 10 mg each of BPC-157 and TB-500.
| KLOW Blend | GLOW Blend | Wolverine Blend | |
|---|---|---|---|
| Vial total | 80 mg | 70 mg | 20 mg |
| GHK-Cu | 50 mg | 50 mg | — |
| BPC-157 | 10 mg | 10 mg | 10 mg |
| TB-500 | 10 mg | 10 mg | 10 mg |
| KPV | 10 mg | — | — |
| Components | 4 | 3 | 2 |
| Relationship | GLOW + KPV | Wolverine + GHK-Cu | BPC-157 + TB-500 core |
In short: if you are asking "klow vs glow", the answer is one extra component, KPV 10 mg, and 10 mg more in the vial (80 mg against 70 mg). Neither listing implies that one performs better than the other; no comparative research exists. Product pages: KLOW Blend, GLOW Blend and Wolverine Blend.
What the Research Says (and What It Does Not)
There are no published studies of KLOW or GLOW as blends. The literature studies each peptide on its own, and almost always in preclinical models: cell cultures and animals. That body of work is the reason these peptides are of interest as research materials, but it does not extend to the mixture. Nothing about combining them has been tested in a way that could be cited, and nothing in the sources below describes effects in people.
For the same reason, this guide makes no claims about what a blend does. Statements such as "the components work together" are a hypothesis at best; they are not an established finding. Anyone using these materials in a laboratory should work from the primary papers on each component and design controls accordingly.
Legal Status in the EU and the WADA List
In the EU these peptides are sold as laboratory reference materials for research. They are not authorised medicines and are not approved for human or veterinary use. National rules on purchasing and handling research peptides vary by country, so check your local regulations before ordering.
For anti-doping purposes, the WADA Prohibited List names some of the components. BPC-157 is listed under S0 (non-approved substances), and thymosin beta-4 and its derivatives, such as TB-500, under S2. Always consult the list for the current year (source 6), since its wording is updated annually.
How to Read the Analysis of a Blend
A mixed vial is harder to verify than a single-peptide vial. In an HPLC run of a blend you expect several peaks, one per component, instead of one dominant peak, so a single "purity %" for the whole vial says little. Analysing each component is more informative. When you review a report for any blend, check:
- Lot match: the lot number on the vial is the lot on the report.
- Date: the report date is plausible for that lot.
- Purity per component: a figure for each peptide, not one number for the mix.
- Identity: mass spectrometry confirming each component is what it claims to be.
- Verifiability: a way to confirm the report on the laboratory's own site.
Pepspan analyses the components by lot at Janoshik Analytical in Prague. The mixed KLOW and GLOW vials themselves have not been analysed by a laboratory; the components have. The KPV analysis is scheduled and will be published when available. Lot pages: KLOW2608 and GLOW2611. The method is explained in the COA verification guide.
| Component | Lot | HPLC purity |
|---|---|---|
| BPC-157 | PEP-BPC157-2607-01 | 99.7% |
| TB-500 | PEP-TB500-2608-01 | 98.45% |
| GHK-Cu | PEP-GHKCU-2607-01 | 99.8% |
| KPV | — | Analysis scheduled |
KLOW and GLOW at Pepspan
Pepspan supplies both as lyophilized research vials: the KLOW Blend (80 mg) and the GLOW Blend (70 mg). Lyophilized material is stable and is best kept refrigerated at 2-8 °C for storage, or at -20 °C for up to 24 months. Pepspan sells these materials for laboratory research only and gives no directions for use. Bacteriostatic water is listed separately as a laboratory consumable: Bacteriostatic Water.
Frequently Asked Questions
What is KLOW peptide?
KLOW peptide is the market name for a four-component research blend in a single 80 mg lyophilized vial: GHK-Cu 50 mg, BPC-157 10 mg, TB-500 10 mg and KPV 10 mg. It is GLOW (GHK-Cu + BPC-157 + TB-500) with KPV added. It is sold as a laboratory reference material, and no studies of the blend itself have been published.
What is in KLOW 80 mg?
The Pepspan KLOW Blend contains GHK-Cu 50 mg (62.5%), BPC-157 10 mg (12.5%), TB-500 10 mg (12.5%) and KPV 10 mg (12.5%), for a total of 80 mg per vial. Other ratios exist on the market, for example 55 mg versions, so check the per-component amounts rather than the name alone.
What is the difference between KLOW and GLOW?
KLOW is GLOW plus KPV. GLOW is a 70 mg vial of GHK-Cu 50 mg, BPC-157 10 mg and TB-500 10 mg; KLOW adds KPV 10 mg to the same three components, giving 80 mg. The amounts of the shared components are identical.
Is KLOW the same as Wolverine?
No. Wolverine is the BPC-157 + TB-500 pair (10 mg + 10 mg, 20 mg in total). It is the core shared by Wolverine, GLOW and KLOW; GLOW adds GHK-Cu to it, and KLOW adds GHK-Cu and KPV.
Are there studies on KLOW?
No studies of the KLOW or GLOW blends as such have been published. The literature covers each peptide separately, almost always in preclinical models (cells and animals). Nothing in it can be read as a statement about the blend or about effects in people.
Is KLOW legal in the EU?
In the EU, KLOW components are sold as laboratory reference materials for research use. They are not authorised medicines and are not approved for human or veterinary use. Rules on buying and handling research peptides differ by country, so check your local regulations.
Is KLOW on the WADA list?
Components of KLOW appear on the WADA Prohibited List: BPC-157 under S0 (non-approved substances) and thymosin beta-4 and its derivatives, such as TB-500, under S2. Check the current-year list at wada-ama.org for exact wording.
Does Pepspan give dosing information?
No. Pepspan sells research reference materials and does not give directions for use, and there is no data on the blend that could support any. Questions about published work on each component are best answered from the primary literature listed below.
What testing does Pepspan's KLOW have?
Pepspan has tested the components by lot at Janoshik Analytical (Prague): BPC-157 lot PEP-BPC157-2607-01 (99.7% HPLC purity), TB-500 lot PEP-TB500-2608-01 (98.45%) and GHK-Cu lot PEP-GHKCU-2607-01 (99.8%). The KPV analysis is scheduled. The mixed vial itself has not been analysed by a laboratory; the components are.
Sources
- Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018;19(7):1987. doi:10.3390/ijms19071987
- Sikiric P, et al. Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications. Curr Neuropharmacol. 2016;14(8):857-865. PubMed 27138887
- Goldstein AL, Hannappel E, Kleinman HK. Thymosin β4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol Med. 2005;11(9):421-429. PubMed 16099219
- Dalmasso G, et al. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. 2008;134(1):166-178. PubMed 18061177
- Brzoska T, et al. Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases. Endocr Rev. 2008;29(5):581-602. PubMed 18612139
- World Anti-Doping Agency. Prohibited List (current year). wada-ama.org/en/prohibited-list
Research Use Only: all products mentioned are intended exclusively for laboratory research and are not for human or veterinary use.